3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Unknown
1
Terminated
1
Sponsor Class
INDUSTRY
43
OTHER
38
OTHER_GOV
2
NIH
1
NETWORK
1
Study Type
Observational
1
Interventional
1
Sponsor
Cancer Type
Gynecologic
3
Tumor-Agnostic
2
Genitourinary
2
Gastrointestinal
2
Head & Neck
1
Conditions
Prostatic Neoplasms
83
Urinary Bladder Neoplasms
31
Carcinoma, Renal Cell
9
Carcinoma, Transitional Cell
8
Kidney Neoplasms
7
Recurrence
5
Prostatic Hyperplasia
5
Neoplasms
5
Disease
5
Testicular Neoplasms
3
Pain, Postoperative
3
Pain
3
Non-Muscle Invasive Bladder Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Anxiety Disorders
3
Sleep Initiation and Maintenance Disorders
2
Penile Neoplasms
2
Pancreatic Neoplasms
2
Motor Activity
2
Melanoma
2
Lymphoma
2
Carcinoma, Hepatocellular
2
Carcinoma
2
Breast Neoplasms
2
Adenocarcinoma
2
Acute Kidney Injury
2
Wilms Tumor
1
Vulvar Neoplasms
1
Vomiting
1
Uterine Cervical Neoplasms
1
Interventions
4-amino-5-fluoro-3-(5-(4-methylpiperazin-1-yl)-1H-benzimidazol-2-yl)quinolin-2(1H)-one
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
OTHER_GOV
×
Carcinoma
×
Genitourinary
×
Clear all
NCT07117409
2025-09-11
RI-NIVO
Azienda USL Reggio Emilia - IRCCS
Terminated
81 enrolled
NCT01791387
2015-02-03
DILIGENCE-1
Auckland District Health Board
Phase 2
Unknown
30 enrolled